Postop Pain Management in Pituitary Tumour Patients

NCT06353529 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Pituitary
Pain, Postoperative

Interventions

DRUG: Bupivacaine-Epinephrine 0.5%-1:200,000 Injectable Solution
DRUG: Placebo
DRUG: Sham Comparator

Sponsor

Hamilton Health Sciences Corporation